Phosphorylation of Estrogen Receptor β at Serine 105 Is Associated with Good Prognosis in Breast Cancer
Authors:
- Abeer M. ShaabanAbeer M. Shaaban
- Valerie SpeirsVSValerie Speirs
- 1 September 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 177 (3) , 1079-1086
Abstract
No abstract availableKeywords
Funding Information
- University of Leeds
- Cancer Research UK
- Breast Cancer Campaign
This publication has 48 references indexed in Scilit:
- Combined analysis of eIF4E and 4E-binding protein expression predicts breast cancer survival and estimates eIF4E activityBritish Journal of Cancer, 2009
- Gene-Expression Signatures in Breast CancerNew England Journal of Medicine, 2009
- Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomasBreast Cancer Research and Treatment, 2008
- A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective studyBreast Cancer Research, 2008
- Clinical Importance of Estrogen Receptor-β Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen TherapyJournal of Clinical Oncology, 2008
- Phosphorylation of Activation Function-1 Regulates Proteasome-Dependent Nuclear Mobility and E6-Associated Protein Ubiquitin Ligase Recruitment to the Estrogen Receptor βMolecular Endocrinology, 2008
- Turning Off Estrogen Receptor β-Mediated Transcription Requires Estrogen-Dependent Receptor ProteolysisMolecular and Cellular Biology, 2006
- Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signalingProceedings of the National Academy of Sciences, 2006
- Ligand‐dependent switching of ubiquitin–proteasome pathways for estrogen receptorThe EMBO Journal, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002